NE

NEUTROGENA CORP

  • CIK: 0000071125
  • EIN: 95-2221471
  • Business address: 5760 W 96TH ST, LOS ANGELES, California, 90045

Information

  • Mailing address
    5760 W 96TH ST, LOS ANGELES, California, 90045
  • Phone
    3106421150
  • State location
    California
  • State of incorporation
    Delaware
  • Fiscal year end
    October 31
  • SIC
    2844 - (CF Office: Office of Life Sciences) PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
  • Filings
    N/A

About NEUTROGENA CORP

NEUTROGENA CORP (CIK: 0000071125) is an American company incorporated in the state of California. Head office is located at 5760 W 96TH ST, LOS ANGELES, California, 90045. Work in the industry 2844 - (CF Office: Office of Life Sciences) PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS. NEUTROGENA CORP is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NEUTROGENA CORP

Filings Format Description Filed/Effective File/Film Number
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0000950157-94-000151 ( Act) Size: 3 KB		 Oct-05-1994

000-07623

94551742
SC 14D1/A Document Acc-no: 0000950157-94-000133 ( Act) Size: 10 KB Sep-26-1994

005-07450

94550334
SC 14D9/A Document

Amendment to Tender offer solicitation / recommendation statements filed under Rule 14d-9

Acc-no: 0000950172-94-000167 ( Act) Size: 7 KB		 Sep-19-1994

005-07450

94549519
SC 14D1/A Document Acc-no: 0000950157-94-000125 ( Act) Size: 7 KB Sep-19-1994

005-07450

94549504
SC 14D1/A Document Acc-no: 0000950157-94-000119 ( Act) Size: 6 KB Sep-09-1994

005-07450

94548604
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000071125-94-000006 ( Act) Size: 33 KB		 Sep-09-1994

000-07623

94548583
SC 14D9/A Document

Amendment to Tender offer solicitation / recommendation statements filed under Rule 14d-9

Acc-no: 0000950172-94-000161 ( Act) Size: 6 KB		 Sep-07-1994

005-07450

94548259
SC 14D1/A Document Acc-no: 0000950157-94-000118 ( Act) Size: 5 KB Sep-07-1994

005-07450

94548251
SC 14D9 Document

Tender offer solicitation / recommendation statements filed under Rule 14d-9

Acc-no: 0000950123-94-001423 ( Act) Size: 268 KB		 Aug-26-1994

005-07450

94546206
SC 14D1 Document Acc-no: 0000950123-94-001422 ( Act) Size: 419 KB Aug-26-1994

005-07450

94546208
8-A12G Document

Form for registration of a class of securities pursuant to section 12(g)

Acc-no: 0000071125-94-000004 ( Act) Size: 17 KB		 Aug-26-1994

000-07623

94546422
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000071125-94-000003 ( Act) Size: 30 KB		 Jun-10-1994

000-07623

94533746
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000071125-94-000002 ( Act) Size: 28 KB		 Mar-11-1994

000-07623

94515600

Recent 20 filings. View all NEUTROGENA CORP filings

Reviews

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • NEUTROGENA CORP overview
  • NEUTROGENA CORP job
  • NEUTROGENA CORP stock
  • NEUTROGENA CORP ownership
  • NEUTROGENA CORP CEO
  • NEUTROGENA CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Empro Group Inc.
Update: Sep 17, 2024
Kenvue Inc.
Update: Jan 05, 2023
Yatsen Holding Ltd
Update: Aug 25, 2022
WILLIAMS J B HOLDINGS INC
Update: Aug 25, 2022
Waldencast plc
Update: Aug 24, 2022
Vilacto Bio Inc.
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4979 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3377 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1699 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3375 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3762 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3737 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1792 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1132 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2284 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by